Search results for: Health Policy and Regulation

Understanding the preferences of people with acute leukemia for different health outcomes

25 September 2025

…future studies and health policy decisions take patient priorities into account. This research paper, Understanding the preferences of people with acute leukemia  for different health outcomes, was commissioned and funded by the Acute…

Around The World in HTAs: Thailand – An Ever-Evolving Policy Tool

9 September 2024

…of Understanding (MOU) on “Collaboration on Priority Setting and Early Health Technology Assessment of Health Innovation in Thailand”, including HITAP, Thailand Science Research and Innovation (TSRI), Thailand Center of Excellence for…

Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison

1 June 2000

…in the UK and the US were, respectively, 20 and 54 percent above the EEC average, whereas those in France and Italy were, respectively, 30 and 28 percent below the…

Impact

…health economists: Healthcare Providers and Hospitals: Health economists help hospitals and healthcare providers optimise resource allocation. They analyse costs, staffing levels, and treatment effectiveness to enhance efficiency and quality of…

The Faces of Regulation: Profit and Price Regulation of the UK Pharmaceutical Industry after the 1998 Competition Act

1 May 2006

…of regulation between the Department of Health as buyer and of the OFT in its role as the agent of general competition law. The paper does not address the OFT…

Around the world in HTAs: China – From fragmentation to function

2 September 2025

…remained informal and fragmented.  In 2016 and 2017, the Ministry of Human Resources and Social Security and the National Health and Family Planning Commission (which is now the National Health…

Do child QALYs = adult QALYs? Five reasons why they might not

4 February 2020

Why might differences arise between child and adult QALYs? In the UK, NICE’s science policy and research team is reviewing NICE’s recommendations on child utilities and QALYs. In Australia, the…

Using Competition with Care: Comment on the Revised Regulations for the NHS

19 March 2013

…of health care funded by the NHS in England. OHE’s Jon Sussex has studied and written extensively on competition in the NHS. He was a member of the OHE Commission…

The Dynamics of Drug Shortages

9 January 2024

…price change of other products with the same molecule, iii) market concentration, iv) demand and competition, and v) patent expiration), which can be used to determine shortages’ factors and value…